首页> 外文期刊>IDrugs: the investigational drugs journal >The Future of Cancer Diagnostics: Next Generation Molecular Technologies - Cambridge Healthtech Institute's Inaugural Conference.
【24h】

The Future of Cancer Diagnostics: Next Generation Molecular Technologies - Cambridge Healthtech Institute's Inaugural Conference.

机译:癌症诊断的未来:下一代分子技术-剑桥健康技术学院成立大会。

获取原文
获取原文并翻译 | 示例
           

摘要

Cambridge Health Tech Institute's first conference on 'The Future of Cancer Diagnostics: Next Generation Molecular Technologies' covered the following areas: regulatory requirements regarding the validation of new cancer diagnostics; how such validation processes might be suitably implemented from laboratory to clinical pipeline to the bedside; translational strategies, such as proteomics or methylation patterns; and novel biomarkers in oncology. Overall in this golden age of cancer research, the aims and objectives of the meeting were to explore how the implementation of new diagnostic strategies could be facilitated. This meeting examined various topics, including 'Early cancer detection', 'Differential diagnosis', 'Prognostic markers and therapy selection' and 'Circulating tumor cells'. The talks and sessions of the meeting are summarized in this report, with particular focus on preclinical and clinical therapies.
机译:剑桥健康技术学院在“癌症诊断的未来:下一代分子技术”的首次会议涉及以下领域:有关验证新癌症诊断的法规要求;从实验室到临床管道再到床边,如何适当实施此类验证过程;蛋白质组学或甲基化模式等翻译策略;以及肿瘤学中的新型生物标志物。总的来说,在这个癌症研究的黄金时代,会议的目的和目的是探讨如何促进新诊断策略的实施。这次会议审查了多个主题,包括“早期癌症检测”,“差异诊断”,“预后标志和疗法选择”以及“循环肿瘤细胞”。本报告总结了会议的讨论和会议,特别着重于临床前和临床疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号